Does gefitinib shorten lung cancer survival? Chaos Redux

被引：7

作者：

Keedy, Vicki L. ^{[1
]}

Arteaga, Carlos L. ^{[1
]}

Johnson, David H. ^{[1
]}

机构：

[1] Vanderbilt Univ, Sch Med, Dept Med, Div Hematol & Oncol, Nashville, TN 37212 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期

关键词：

D O I：

10.1200/JCO.2008.16.0374

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

引用

页码：2428 / 2430

页数：3

共 26 条

[1]

Anido J, 2003, CLIN CANCER RES, V9, P1274

[2]

Unliganded epidermal growth factor receptor dimerization induced by direct interaction of quinazolines with the ATP binding site [J].

Arteaga, CL ;

Ramsey, TT ;

Shawver, LK ;

Guyer, CA .

JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (37) :23247-23254

[3]

Epidermal growth factor receptor mutations and gene amplification in non-small-cell lung cancer: Molecular analysis of the IDEAL/INTACT gefitinib trials [J].

Bell, DW ;

Lynch, TJ ;

Haserlat, SM ;

Harris, PL ;

Okimoto, RA ;

Brannigan, BW ;

Sgroi, DC ;

Muir, B ;

Riemenschneider, MJ ;

Iacona, RB ;

Krebs, AD ;

Johnson, DH ;

Giaccone, G ;

Herbst, RS ;

Manegold, C ;

Fukuoka, M ;

Kris, MG ;

Baselga, J ;

Ochs, JS ;

Haber, DA .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (31) :8081-8092

[4]

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck [J].

Bonner, JA ;

Harari, PM ;

Giralt, J ;

Azarnia, N ;

Shin, DM ;

Cohen, RB ;

Jones, CU ;

Sur, R ;

Raben, D ;

Jassem, J ;

Ove, R ;

Kies, MS ;

Baselga, J ;

Youssoufian, H ;

Amellal, N ;

Rowinsky, EK ;

Ang, KK .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (06) :567-578

[5]

Gefitinib (IRESSA) versus docetaxel in patients with locally advanced or metastatic non-small-cell lung cancer pre-treated with platinum-based chemotherapy: a randomized, open-label Phase III study (INTEREST) [J].

Douillard, Jean-Yves ;

Kim, Edward ;

Hirsh, Vera ;

Mok, Tony ;

Socinski, Mark ;

Gervais, Radj ;

Wu, Yi-Long ;

Li, Longyun ;

Sellers, Mark ;

Lowe, Elizabeth .

JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) :S305-S306

[6]

Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib [J].

Eberhard, DA ;

Johnson, BE ;

Amler, LC ;

Goddard, AD ;

Heldens, SL ;

Herbst, RS ;

Ince, WL ;

Jänne, PA ;

Januario, T ;

Johnson, DH ;

Klein, P ;

Miller, VA ;

Ostland, MA ;

Ramies, DA ;

Sebisanovic, D ;

Stinson, JA ;

Zhang, YR ;

Seshagiri, S ;

Hillan, KJ .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (25) :5900-5909

[7]

A small molecule-kinase interaction map for clinical kinase inhibitors [J].

Fabian, MA ;

Biggs, WH ;

Treiber, DK ;

Atteridge, CE ;

Azimioara, MD ;

Benedetti, MG ;

Carter, TA ;

Ciceri, P ;

Edeen, PT ;

Floyd, M ;

Ford, JM ;

Galvin, M ;

Gerlach, JL ;

Grotzfeld, RM ;

Herrgard, S ;

Insko, DE ;

Insko, MA ;

Lai, AG ;

Lélias, JM ;

Mehta, SA ;

Milanov, ZV ;

Velasco, AM ;

Wodicka, LM ;

Patel, HK ;

Zarrinkar, PP ;

Lockhart, DJ .

NATURE BIOTECHNOLOGY, 2005, 23 (03) :329-336

[8]

Epidermal growth factor receptor inhibitors plus chemotherapy in non-small-cell lung cancer: Biologic rationale for combination strategies [J].

Gandara, David R. ;

Davies, Angela M. ;

Gautschi, Oliver ;

Mack, Philip C. ;

Lau, Derick H. ;

Lara, Prinio N., Jr. ;

Hirsch, Fred R. .

CLINICAL LUNG CANCER, 2007, 8 :S61-S67

[9]

Epidermal growth factor receptor tyrosine kinase inhibitors plus chemotherapy: Case closed or is the jury still out? [J].

Gandara, DR ;

Gumerlock, PH .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (25) :5856-5858

[10]

Phase III study of erlotinib in combination with cisplatin and gemcitabine in advanced non-small-cell lung cancer: The Tarceva Lung Cancer Investigation Trial [J].

Gatzemeier, Ulrich ;

Pluzanska, Anna ;

Szczesna, Aleksandra ;

Kaukel, Eckhard ;

Roubec, Jaromir ;

De Rosa, Flavio ;

Milanowski, Janusz ;

Karnicka-Mlodkowski, Hanna ;

Pesek, Milos ;

Serwatowski, Piotr ;

Ramlau, Rodryg ;

Janaskova, Terezie ;

Vansteenkiste, Johan ;

Strausz, Janos ;

Manikhas, Georgy Moiseevich ;

Von Pawel, Joachim .

JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (12) :1545-1552

← 1 2 3 →